Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor

Hong Wang, Paul R. Carlier, Wing Lok Ho, Nelson Tze Kin Lee, Yuan-Ping Pang, Yi Fan Han

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

AIM: To study the effects of 1,7-N-heptylene-bis-9,9'-amino-1,2, 3,4- tetrahydroacridine [bis (7)-tacrine], a novel dimeric acetylcholinesterase inhibitor (AChEI) derived from 9-amino-1,2,3,4-tetrahydroaminoacridine (tacrine), on scopolamine-induced spatial memory impairment. METHODS: The effects of bis(7)-tacrine were investigated on the 5-d performance of young adult rats in the Morris water maze. The latency to find the platform in the water maze was measured to evaluate performance. Tactine was used as a reference drug. RESULTS: Scopolamine (0.3 mg · kg-1, ip) resulted in an increase in latency period (> 100 % increase) as compared with saline treated controls. Both his (7)-tacrine and tactine lessened the increased latency induced by scopolamine to the level of saline control group. The relative potency of his (7)-tacrine (0.35 μmol · kg-1, ig or ip) to shorten the escape latency was 24 or 12 times of tactine (8.52 μmol · kg-1 ig, 4.26 μmol · kg-1 ip) following ig or ip administration, respectively. There appeared to be an inverse bell-shape dose-dependent effect for both compounds tested. CONCLUSION: Bis (7)-tacrine is a more potent and orally active AChEI than tactine, and has potential for the palliative treatment of Alzheimer disease.

Original languageEnglish (US)
Pages (from-to)211-217
Number of pages7
JournalActa Pharmacologica Sinica
Volume20
Issue number3
StatePublished - 1999

Fingerprint

Tacrine
Scopolamine Hydrobromide
Rats
Data storage equipment
Cholinesterase Inhibitors
Water
Palliative Care
Young Adult
Alzheimer Disease
Control Groups
Pharmaceutical Preparations

Keywords

  • Alzheimer disease
  • Bis (7)-tacrine
  • Cholinesterase inhibitors
  • Memory
  • Morris water maze
  • Scopolamine
  • Tacrine

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmacology

Cite this

Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. / Wang, Hong; Carlier, Paul R.; Ho, Wing Lok; Lee, Nelson Tze Kin; Pang, Yuan-Ping; Han, Yi Fan.

In: Acta Pharmacologica Sinica, Vol. 20, No. 3, 1999, p. 211-217.

Research output: Contribution to journalArticle

Wang, Hong ; Carlier, Paul R. ; Ho, Wing Lok ; Lee, Nelson Tze Kin ; Pang, Yuan-Ping ; Han, Yi Fan. / Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. In: Acta Pharmacologica Sinica. 1999 ; Vol. 20, No. 3. pp. 211-217.
@article{393f2fbd8fdc41ae995352a7c535bbd2,
title = "Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor",
abstract = "AIM: To study the effects of 1,7-N-heptylene-bis-9,9'-amino-1,2, 3,4- tetrahydroacridine [bis (7)-tacrine], a novel dimeric acetylcholinesterase inhibitor (AChEI) derived from 9-amino-1,2,3,4-tetrahydroaminoacridine (tacrine), on scopolamine-induced spatial memory impairment. METHODS: The effects of bis(7)-tacrine were investigated on the 5-d performance of young adult rats in the Morris water maze. The latency to find the platform in the water maze was measured to evaluate performance. Tactine was used as a reference drug. RESULTS: Scopolamine (0.3 mg · kg-1, ip) resulted in an increase in latency period (> 100 {\%} increase) as compared with saline treated controls. Both his (7)-tacrine and tactine lessened the increased latency induced by scopolamine to the level of saline control group. The relative potency of his (7)-tacrine (0.35 μmol · kg-1, ig or ip) to shorten the escape latency was 24 or 12 times of tactine (8.52 μmol · kg-1 ig, 4.26 μmol · kg-1 ip) following ig or ip administration, respectively. There appeared to be an inverse bell-shape dose-dependent effect for both compounds tested. CONCLUSION: Bis (7)-tacrine is a more potent and orally active AChEI than tactine, and has potential for the palliative treatment of Alzheimer disease.",
keywords = "Alzheimer disease, Bis (7)-tacrine, Cholinesterase inhibitors, Memory, Morris water maze, Scopolamine, Tacrine",
author = "Hong Wang and Carlier, {Paul R.} and Ho, {Wing Lok} and Lee, {Nelson Tze Kin} and Yuan-Ping Pang and Han, {Yi Fan}",
year = "1999",
language = "English (US)",
volume = "20",
pages = "211--217",
journal = "Zhongguo yao li xue bao = Acta pharmacologica Sinica",
issn = "1671-4083",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor

AU - Wang, Hong

AU - Carlier, Paul R.

AU - Ho, Wing Lok

AU - Lee, Nelson Tze Kin

AU - Pang, Yuan-Ping

AU - Han, Yi Fan

PY - 1999

Y1 - 1999

N2 - AIM: To study the effects of 1,7-N-heptylene-bis-9,9'-amino-1,2, 3,4- tetrahydroacridine [bis (7)-tacrine], a novel dimeric acetylcholinesterase inhibitor (AChEI) derived from 9-amino-1,2,3,4-tetrahydroaminoacridine (tacrine), on scopolamine-induced spatial memory impairment. METHODS: The effects of bis(7)-tacrine were investigated on the 5-d performance of young adult rats in the Morris water maze. The latency to find the platform in the water maze was measured to evaluate performance. Tactine was used as a reference drug. RESULTS: Scopolamine (0.3 mg · kg-1, ip) resulted in an increase in latency period (> 100 % increase) as compared with saline treated controls. Both his (7)-tacrine and tactine lessened the increased latency induced by scopolamine to the level of saline control group. The relative potency of his (7)-tacrine (0.35 μmol · kg-1, ig or ip) to shorten the escape latency was 24 or 12 times of tactine (8.52 μmol · kg-1 ig, 4.26 μmol · kg-1 ip) following ig or ip administration, respectively. There appeared to be an inverse bell-shape dose-dependent effect for both compounds tested. CONCLUSION: Bis (7)-tacrine is a more potent and orally active AChEI than tactine, and has potential for the palliative treatment of Alzheimer disease.

AB - AIM: To study the effects of 1,7-N-heptylene-bis-9,9'-amino-1,2, 3,4- tetrahydroacridine [bis (7)-tacrine], a novel dimeric acetylcholinesterase inhibitor (AChEI) derived from 9-amino-1,2,3,4-tetrahydroaminoacridine (tacrine), on scopolamine-induced spatial memory impairment. METHODS: The effects of bis(7)-tacrine were investigated on the 5-d performance of young adult rats in the Morris water maze. The latency to find the platform in the water maze was measured to evaluate performance. Tactine was used as a reference drug. RESULTS: Scopolamine (0.3 mg · kg-1, ip) resulted in an increase in latency period (> 100 % increase) as compared with saline treated controls. Both his (7)-tacrine and tactine lessened the increased latency induced by scopolamine to the level of saline control group. The relative potency of his (7)-tacrine (0.35 μmol · kg-1, ig or ip) to shorten the escape latency was 24 or 12 times of tactine (8.52 μmol · kg-1 ig, 4.26 μmol · kg-1 ip) following ig or ip administration, respectively. There appeared to be an inverse bell-shape dose-dependent effect for both compounds tested. CONCLUSION: Bis (7)-tacrine is a more potent and orally active AChEI than tactine, and has potential for the palliative treatment of Alzheimer disease.

KW - Alzheimer disease

KW - Bis (7)-tacrine

KW - Cholinesterase inhibitors

KW - Memory

KW - Morris water maze

KW - Scopolamine

KW - Tacrine

UR - http://www.scopus.com/inward/record.url?scp=13044286787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13044286787&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 211

EP - 217

JO - Zhongguo yao li xue bao = Acta pharmacologica Sinica

JF - Zhongguo yao li xue bao = Acta pharmacologica Sinica

SN - 1671-4083

IS - 3

ER -